3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Preleukemia
1
Myelodysplastic Syndromes
1
Leukemia
1
Hematologic Diseases
1
Cytopenia
1
Bone Marrow Diseases
1
Anemia
1
Interventions
AP 1903 reagent
3
ON 01910
2
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
cedazuridine
1
Therapeutics
1
Sertraline
1
Peripheral Blood Stem Cell Transplantation
1
Interleukin-8
1
IDO-1 inhibitor LY3381916
1
HuMax-IL8
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Exercise
1
Decitabine
1
DNA
1
Cyclophosphamide
1
Cord Blood Stem Cell Transplantation
1
Busulfan
1
Bone Marrow Transplantation
1
Biopsy
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytopenia
×
Sertraline
×
Myeloid
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled